Aller au contenu principal
Profil bibliographique

Vinita Elizabeth Jacob

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

45Publications signalées
1877Citations signalées
1Affiliations récentes

Les institutions déclarées

Les domaines associés

Inflammatory Bowel DiseaseGut microbiota and healthMicroscopic ColitisClostridium difficile and Clostridium perfringens researchEosinophilic Esophagitis

Les publications récentes

Accès ouvert 2026 article OpenAlex

Caspase 5c amplifies Wnt via APC cleavage to promote intestinal homeostasis

Baosen Jia, Yuhua Shi, Yourae Hong, Chongbo Yang et autres

Caspase 5 (CASP5) is a member of the inflammatory caspase family of cysteine proteases that is involved in inflammation and cell death1–3. CASP5 shares the highest homology with inflammatory CASP4, but whereas CASP4 is essential for noncanonical inflammasome activation, CASP5 is dispensable4–6, …

us, gb, be (code pays fourni par la source)

3 citations Nature
Accès ouvert 2025 article OpenAlex

Altered Gut Microbiota in Pediatric Quiescent Crohn’s Disease Patients with Iron Deficiency Anemia

Elliott Gordon, Jérémy Goc, Alexander R. Grier, Charlene Thomas et autres

BACKGROUND: Iron deficiency anemia (IDA) is the most common extra-intestinal complication in inflammatory bowel disease (IBD). The persistence of iron deficiency in patients living with quiescent IBD remains poorly understood. Given the extensive body of research linking IBD pathogenesis to microbiome disruptions, …

us (code pays fourni par la source)

1 citation Inflammatory Bowel Diseases
2025 conference-abstract OpenAlex

S1540 Effectiveness of Combination Biologic and/or Small Molecule Therapies in Inflammatory Bowel Disease: A Single Center Analysis

Jacob K.R. Jamison, Anjile An, Caroline J. Young, Michael J Mintz et autres

Introduction: Despite an increasing variety of treatment options, many inflammatory bowel disease (IBD) patients do not achieve therapy goals. Plateauing efficacy of single-agent regimens is commonly reported even after therapy optimization. This study evaluates the effectiveness of combination regimens including newer agents …

0 citations The American Journal of Gastroenterology
2025 conference-abstract OpenAlex

S1539 Safety of Combination Biologic and/or Small Molecule Therapies in Inflammatory Bowel Disease: A Single-Center Analysis

Jacob K.R. Jamison, Anjile An, Caroline J. Young, Michael J Mintz et autres

Introduction: Despite an increasing variety of treatment options, many inflammatory bowel disease (IBD) patients do not achieve therapy goals. Many require hospitalization and high-risk interventions, such as steroids or surgery. This study evaluates the safety of combination regimens including newer agents in …

0 citations The American Journal of Gastroenterology
2024 conference-abstract OpenAlex

S3815 Macrophage Activation Syndrome Complicated By Fatal Gastrointestinal Bleed

Elizabeth Reznik, Emily E. Smith, Vinita Elizabeth Jacob

Introduction: Macrophage Activation Syndrome (MAS) is a rare, potentially fatal complication of systemic inflammatory disorders that belongs to a group of disorders called Hemophagocytic Lymphohistiocytosis (HLH). It is characterized by inappropriate activation of T lymphocytes and macrophages resulting in fevers, hepatosplenomegaly, pancytopenia, …

1 citation The American Journal of Gastroenterology
Accès ouvert 2024 article OpenAlex

Dietary fiber is a critical determinant of pathologic ILC2 responses and intestinal inflammation

Mohammad Arifuzzaman, Tae Hyung Won, Hiroshi Yano, Jazib Uddin et autres

Innate lymphoid cells (ILCs) can promote host defense, chronic inflammation, or tissue protection and are regulated by cytokines and neuropeptides. However, their regulation by diet and microbiota-derived signals remains unclear. We show that an inulin fiber diet promotes Tph1-expressing inflammatory ILC2s (ILC2INFLAM) …

us (code pays fourni par la source)

56 citations The Journal of Experimental Medicine

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.